Literature DB >> 11907022

The medical management of valvar heart disease.

N A Boon1, P Bloomfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11907022      PMCID： PMC1767079          DOI： 10.1136/heart.87.4.395

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  19 in total

Review 1.  Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.

Authors:  C Gohlke-Bärwolf
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

Review 2.  Clinical practice. Evaluation and management of chronic mitral regurgitation.

Authors:  C M Otto
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

3.  Are atherosclerotic processes involved in aortic-valve calcification?

Authors:  E R Mohler
Journal:  Lancet       Date:  2000-08-12       Impact factor: 79.321

4.  New insights into the progression of aortic stenosis: implications for secondary prevention.

Authors:  S Palta; A M Pai; K S Gill; R G Pai
Journal:  Circulation       Date:  2000-05-30       Impact factor: 29.690

Review 5.  Why deny ACE inhibitors to patients with aortic stenosis?

Authors:  N L Cox; A R Abdul-Hamid; G P Mulley
Journal:  Lancet       Date:  1998-07-11       Impact factor: 79.321

6.  Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse.

Authors:  M D Tischler; M Rowan; M M LeWinter
Journal:  Am J Cardiol       Date:  1998-07-15       Impact factor: 2.778

7.  Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis.

Authors:  G M Novaro; I Y Tiong; G L Pearce; M S Lauer; D L Sprecher; B P Griffin
Journal:  Circulation       Date:  2001-10-30       Impact factor: 29.690

Review 8.  Vasodilator therapy for chronic aortic and mitral regurgitation.

Authors:  P A Grayburn
Journal:  Am J Med Sci       Date:  2000-09       Impact factor: 2.378

Review 9.  ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).

Authors: 
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

10.  Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial.

Authors:  B Greenberg; B Massie; J D Bristow; M Cheitlin; D Siemienczuk; N Topic; R A Wilson; J Szlachcic; D Thomas
Journal:  Circulation       Date:  1988-07       Impact factor: 29.690
View more
  5 in total

Review 1.  Choice of heart valve prosthesis.

Authors:  Peter Bloomfield
Journal:  Heart       Date:  2002-06       Impact factor: 5.994

2.  Heart valve disease in general practice: a clinical overview.

Authors:  Jessica Webb; Chris Arden; John B Chambers
Journal:  Br J Gen Pract       Date:  2015-03       Impact factor: 5.386

Review 3.  Diagnosis and Management of Acute Heart Failure in Sub-Saharan Africa.

Authors:  Alice Kidder Bukhman; Vizir Jean Paul Nsengimana; Mindy C Lipsitz; Patricia C Henwood; Endale Tefera; Shada A Rouhani; Damas Dukundane; Gene Y Bukhman
Journal:  Curr Cardiol Rep       Date:  2019-08-31       Impact factor: 2.931

Review 4.  Medical Therapies for Marfan Syndrome and Other Thoracic Aortic Dilatation in Adults: A Contemporary Review.

Authors:  Duygu Kocyigit; Brian P Griffin; Bo Xu
Journal:  Am J Cardiovasc Drugs       Date:  2021-03-22       Impact factor: 3.571

5.  Reduced Long-Term Relative Survival in Females and Younger Adults Undergoing Cardiac Surgery: A Prospective Cohort Study.

Authors:  Tone Bull Enger; Hilde Pleym; Roar Stenseth; Guri Greiff; Alexander Wahba; Vibeke Videm
Journal:  PLoS One       Date:  2016-09-28       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.